ATH alterity therapeutics limited

Ann: Appendix 4E Preliminary Final Report, page-4

  1. 141 Posts.
    lightbulb Created with Sketch. 18
    I think its all absolutely fine. They are in the business end of a RCT that's fully enrolled with a number of patients already through the 12 month assessment. They have spent lots on r+d but what else would one expect.

    roughly 6M coming in 2025 through R+D rebate.

    its all about the q1 2025 readout. Boom or bust
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.6¢
Change
0.001(6.67%)
Mkt cap ! $147.3M
Open High Low Value Volume
1.5¢ 1.7¢ 1.5¢ $770.2K 49.71M

Buyers (Bids)

No. Vol. Price($)
8 2038332 1.5¢
 

Sellers (Offers)

Price($) Vol. No.
1.6¢ 349000 2
View Market Depth
Last trade - 16.10pm 25/07/2025 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.